Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 233

    Meet the new boss of CPHI Europe

    Tara Dougal

    / CPHI

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tara Dougal, Event Director – Pharma (CPHI Europe). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tara, covering: Tara brings over 12 years of extensive event management experience spanning roles in

  • Episode 232

    30 years on the rollercoaster of clinical trials

    Claire Riches

    / Citeline

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Riches, Vice President, Clinical Solutions at Citeline. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Claire, covering: With over 30 years’ experience in the life science sector, Claire is a

  • Episode 231

    The rain-making, 2X exit founder

    Andrea Wagner

    / PharmaPhixx

    Boston’s Dr. Andrea N. Wagner, CEO at PharmaPhixx, shares her journey in sterile manufacturing, entrepreneurship, and empowering women in STEM.

  • Episode 230

    The Indian CEO driving change

    Ankit Gupta

    / Tenshi Kaizen & InstaPill

    Explore India’s evolving pharma landscape with Ankit Gupta, CEO at Tenshi Kaizen, as he shares insights on drug delivery innovation, CDMO growth, and strategic leadership in biopharma.

  • Episode 229

    40 years, 6 exits – a CEO addict

    Adam Sherlock

    / Qinecsa

    Explore the journey of Adam Sherlock, CEO at Qinecsa, as he shares insights on M&A, leadership, and the future of R&D.

  • Episode 228

    CDMO Live rewind: Industry leaders on the future of pharma

    Raman Sehgal, Gil Roth, Dr. Jim Li, Kaan-Fabian Kekec

    / Molecule to Market, PBOA, BioDuro-Sundia, Simon-Kucher

    Panel insights from CDMO Live 2025: Experts discuss funding strain, pricing shifts, global trade impact, and future-proofing strategies for pharma outsourcing.

  • Episode 227

    The learning curve of a biotech founder/CSO

    Hella Kohlhof

    / Immunic Therapeutics

    Join Immunic CSO Dr. Hella Kohlhof as she shares biotech insights on global outsourcing, Nasdaq growth, and scientific leadership.

  • Episode 226

    The cancer Doc, driven by impact

    Tim Showalter

    / ArteraAI

    Explore how Dr. Tim Showalter, Radiation Oncologist and CMO at ArteraAI, is transforming prostate cancer care with AI-powered diagnostics.

  • Episode 225

    The GM focused on inhaled & nasal drugs

    Gemma Budd

    / Nanopharm

    Gemma Budd, GM at Nanopharm, shares insights on inhalation drug delivery, CRO leadership, and driving pharmaceutical innovation in nasal and pulmonary therapies.

  • Episode 224

    The impact of a CEO who loves to work

    Jeanne Taylor Hecht

    / Lexitas

    Meet Jeanne Lexitas CEO & Chairwoman, biotech board leader, ophthalmology CRO specialist, and global pharma advisor passionate about patient-focused innovation.

  • Load more